结直肠疾病的诊疗进展(摘译)

血清miR-21作为结直肠癌的诊断和预后生物标志物 Serum miR-21 asa diagnostic and prognostic biomarker in colorectal cancer[J].[日本]Toiyama Y,Tokahashi M,Hur K,et al.J Natl Cancer Inst,2013,105(12):849-859.背景致癌性微小RNA miR-21和miR-31为负调节抑癌基因.其能否作为血清生物标志物用于人类结直肠癌的探查仍未确定.方法 为了测定miR-21和miR-31是否是分泌性miRNA,笔者筛查了2株结直肠癌细胞系的培养基中miRNA的表... View More